Health Problems

For men, low testosterone means high risk of severe COVID-19

Throughout the pandemic, doctors have seen evidence that men with COVID-19 fare worse, on average, than women with the infection. One theory is that hormonal differences between men and women may make men more susceptible to severe disease. And since men have much more testosterone than women, some scientists have speculated that high levels of […]

Health Problems

Neglected Tropical Diseases (NTDs) and Vaccines

Current estimates indicate that over 1 billion of the world’s poorest people are affected by neglected tropical diseases (NTDs). NTDs are typically found in areas of extreme poverty within Africa, Asia, and Latin America. Image Credit: bsd/Shutterstock.com Introduction By definition, a neglected tropical disease is a disease that causes significant illness for people around the […]

Health Problems

pacritinib

pacritinib CTI BioPharma Announces Completion of Rolling Submission of New Drug Application (NDA) for Pacritinib in Myelofibrosis Patients with Severe Thrombocytopenia SEATTLE, March 31, 2021 /PRNewswire/ — CTI BioPharma Corp. (Nasdaq: CTIC) today announced that it has completed a rolling New Drug Application (“NDA”) submission to the U.S. Food and Drug Administration (“FDA”) seeking approval of pacritinib as a treatment for […]

Health Problems

A Guide to Looking After Your Mental Health

According to the World Health Organisation (WHO), health is “A state of complete physical, mental and social well-being and not merely the absence of disease.” Image Credit: A Plus Vector /Shutterstock.com The importance of looking after physical health by adopting a healthy lifestyle is a familiar concept. It is widely accepted that adopting behaviors such […]

Health Problems

atogepant

atogepant U.S. FDA Accepts AbbVie’s New Drug Application for Atogepant for the Preventive Treatment of Migraine NORTH CHICAGO, Ill., March 30, 2021 /PRNewswire/ — AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) for atogepant, an investigational orally administered calcitonin gene-related peptide (CGRP) receptor antagonist (gepant), […]

Health Problems

udenafil

udenafil Mezzion Announces Re-Submission of New Drug Application for its Orphan Drug Udenafil to Treat Patients who have undergone the Fontan Operation for Single Ventricle Heart Disease SEOUL, South Korea, March 28, 2021 /PRNewswire/ — Mezzion Pharma Co. Ltd. (140410.KQ), announced today that it has re-submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for […]

Health Problems

What is Peripheral Arterial Disease?

Peripheral arterial disease/peripheral artery disease (PAD), or peripheral vascular disease (PVD) is a common condition where bodily arteries become narrowed due to a build-up of fatty plaques (atherosclerosis). Image Credit: Anshuman Rath/Shutterstock.com What causes peripheral arterial disease? Atherosclerosis is the build-up of fatty deposits called atheromatous plaques within the walls of major blood vessels (arteries) […]

Health Problems

The Search for a Universal Coronavirus Vaccine

The global COVID-19 vaccine roll-out is providing hope of permanently moving out of the harsh restrictions that have been enforced intermittently since the COVID-19 outbreak was declared a pandemic in early 2020. However, emerging new strains of the virus such as the UK strain, the South African and the Brazilian, are triggering concerns over whether […]

Health Problems

What is Neuropsychiatric Lupus (NPSLE)?

Neuropsychiatric lupus (NPSLE), which is often referred to as central nervous system (CNS) lupus, can cause lupus patients to be afflicted with a variety of neuropsychiatric issues ranging from headaches and depression to seizures and a number of demyelinating conditions. Image Credit: vitstudio / Shutterstock.com Overview of lupus Systemic lupus erythematosus (SLE), which is formally […]

Health Problems

FT218

Avadel Pharmaceuticals Announces FDA Acceptance of New Drug Application for FT218 in Adults with Narcolepsy for the Treatment of Excessive Daytime Sleepiness and Cataplexy DUBLIN, Ireland, March 01, 2021 (GLOBE NEWSWIRE) — Avadel Pharmaceuticals plc (Nasdaq: AVDL) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Company’s New Drug Application (NDA) for FT218, an investigational, once-nightly […]